Clinical Trials
20 trialsA Study of TAK-505 in Adults With Solid Tumors
Takeda
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
National Institutes of Health Clinical Center (CC)
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
Memorial Sloan Kettering Cancer Center
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting
The First Affiliated Hospital of Xinxiang Medical College
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
Peking University Cancer Hospital & Institute
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
The First Affiliated Hospital of Guangzhou Medical University
First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Chinese PLA General Hospital
A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
SARMET
Sanofi
Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors
Tianjin Medical University Cancer Institute and Hospital
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan
AstraZeneca